492 related articles for article (PubMed ID: 25665170)
1. Sex-based memory advantages and cognitive aging: a challenge to the cognitive reserve construct?
Caselli RJ; Dueck AC; Locke DE; Baxter LC; Woodruff BK; Geda YE
J Int Neuropsychol Soc; 2015 Feb; 21(2):95-104. PubMed ID: 25665170
[TBL] [Abstract][Full Text] [Related]
2. Female advantage in verbal memory: Evidence of sex-specific cognitive reserve.
Sundermann EE; Maki PM; Rubin LH; Lipton RB; Landau S; Biegon A;
Neurology; 2016 Nov; 87(18):1916-1924. PubMed ID: 27708128
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal changes in cognition and behavior in asymptomatic carriers of the APOE e4 allele.
Caselli RJ; Reiman EM; Osborne D; Hentz JG; Baxter LC; Hernandez JL; Alexander GG
Neurology; 2004 Jun; 62(11):1990-5. PubMed ID: 15184602
[TBL] [Abstract][Full Text] [Related]
4. Do apolipoprotein E genotype and educational attainment predict the rate of cognitive decline in normal aging? A 12-year follow-up of the Maastricht Aging Study.
Van Gerven PW; Van Boxtel MP; Ausems EE; Bekers O; Jolles J
Neuropsychology; 2012 Jul; 26(4):459-72. PubMed ID: 22642392
[TBL] [Abstract][Full Text] [Related]
5. Female APOE ɛ4 Carriers with Slow Rates of Biological Aging Have Better Memory Performances Compared to Female ɛ4 Carriers with Accelerated Aging.
O'Shea DM; Galvin JE
J Alzheimers Dis; 2023; 92(4):1269-1282. PubMed ID: 36872781
[TBL] [Abstract][Full Text] [Related]
6. APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.
Dik MG; Jonker C; Bouter LM; Geerlings MI; van Kamp GJ; Deeg DJ
Neurology; 2000 Apr; 54(7):1492-7. PubMed ID: 10751265
[TBL] [Abstract][Full Text] [Related]
7. Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals.
Pettigrew C; Nazarovs J; Soldan A; Singh V; Wang J; Hohman T; Dumitrescu L; Libby J; Kunkle B; Gross AL; Johnson S; Lu Q; Engelman C; Masters CL; Maruff P; Laws SM; Morris JC; Hassenstab J; Cruchaga C; Resnick SM; Kitner-Triolo MH; An Y; Albert M
Alzheimers Res Ther; 2023 Mar; 15(1):66. PubMed ID: 36978190
[TBL] [Abstract][Full Text] [Related]
8. A gender difference in the association between APOE genotype and age-related cognitive decline.
Mortensen EL; Høgh P
Neurology; 2001 Jul; 57(1):89-95. PubMed ID: 11445633
[TBL] [Abstract][Full Text] [Related]
9. Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.
Dik MG; Jonker C; Comijs HC; Bouter LM; Twisk JW; van Kamp GJ; Deeg DJ
Neurology; 2001 Dec; 57(12):2217-22. PubMed ID: 11756600
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological correlates of hippocampal atrophy in memory testing in nondemented older adults.
Vyhnalek M; Nikolai T; Andel R; Nedelska Z; Rubínová E; Marková H; Laczó J; Bezdicek O; Sheardova K; Hort J
J Alzheimers Dis; 2014; 42 Suppl 3():S81-90. PubMed ID: 24670399
[TBL] [Abstract][Full Text] [Related]
11. Education Moderates the Relation Between APOE ɛ4 and Memory in Nondemented Non-Hispanic Black Older Adults.
Vonk JMJ; Arce Rentería M; Medina VM; Pericak-Vance MA; Byrd GS; Haines J; Brickman AM; Manly JJ
J Alzheimers Dis; 2019; 72(2):495-506. PubMed ID: 31594222
[TBL] [Abstract][Full Text] [Related]
12. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
Stonnington CM; Snyder PJ; Hentz JG; Reiman EM; Caselli RJ
J Clin Psychiatry; 2009 Oct; 70(10):1379-84. PubMed ID: 19573495
[TBL] [Abstract][Full Text] [Related]
13. APOE E4 status predicts age-related cognitive decline in the ninth decade: longitudinal follow-up of the Lothian Birth Cohort 1921.
Schiepers OJ; Harris SE; Gow AJ; Pattie A; Brett CE; Starr JM; Deary IJ
Mol Psychiatry; 2012 Mar; 17(3):315-24. PubMed ID: 21263443
[TBL] [Abstract][Full Text] [Related]
14. APOE ε4 Genotype and Cognitive Reserve Effects on the Cognitive Functioning of Healthy Elders.
López ME; Turrero A; Delgado ML; Rodríguez-Rojo IC; Arrazola J; Barabash A; Maestú F; Fernández A
Dement Geriatr Cogn Disord; 2017; 44(5-6):328-342. PubMed ID: 29414814
[TBL] [Abstract][Full Text] [Related]
15. APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.
Lim YY; Villemagne VL; Laws SM; Pietrzak RH; Snyder PJ; Ames D; Ellis KA; Harrington K; Rembach A; Martins RN; Rowe CC; Masters CL; Maruff P
Mol Psychiatry; 2015 Nov; 20(11):1322-8. PubMed ID: 25288138
[TBL] [Abstract][Full Text] [Related]
16. Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes.
Caselli RJ; Dueck AC; Locke DE; Sabbagh MN; Ahern GL; Rapcsak SZ; Baxter LC; Yaari R; Woodruff BK; Hoffman-Snyder C; Rademakers R; Findley S; Reiman EM
Neurology; 2011 Mar; 76(12):1078-84. PubMed ID: 21325652
[TBL] [Abstract][Full Text] [Related]
17. Women Outperform Men in Verbal Episodic Memory Even in Oldest-Old Age: 13-Year Longitudinal Results of the AgeCoDe/AgeQualiDe Study.
Golchert J; Roehr S; Luck T; Wagner M; Fuchs A; Wiese B; van den Bussche H; Brettschneider C; Werle J; Bickel H; Pentzek M; Oey A; Eisele M; König HH; Weyerer S; Mösch E; Maier W; Scherer M; Heser K; Riedel-Heller SG
J Alzheimers Dis; 2019; 69(3):857-869. PubMed ID: 31127762
[TBL] [Abstract][Full Text] [Related]
18. Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume.
Caldwell JZK; Berg JL; Cummings JL; Banks SJ;
Alzheimers Res Ther; 2017 Sep; 9(1):72. PubMed ID: 28899422
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E genotype and memory in the sixth decade of life.
Schultz MR; Lyons MJ; Franz CE; Grant MD; Boake C; Jacobson KC; Xian H; Schellenberg GD; Eisen SA; Kremen WS
Neurology; 2008 May; 70(19 Pt 2):1771-7. PubMed ID: 18235080
[TBL] [Abstract][Full Text] [Related]
20. Impact of APOE status on cognitive maintenance in healthy elderly persons.
Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
